Thousands of Blood Pressure Pill Bottles Recalled

Macleods Pharmaceuticals initiated a nationwide recall of over 3,700 bottles of blood pressure medication on October 7, 2026. The recall was prompted by "failed dissolution specifications," a critical issue where the drug may not release its active ingredients at the proper rate within the body. Consequently, these pills might be ineffective in managing high blood pressure as expected.

The U.S. Food and Drug Administration (FDA) has designated this recall as Class II. This classification signifies that the recalled medication could potentially lead to temporary or medically reversible adverse health effects. However, the FDA also noted that it is unlikely to cause serious health consequences.

Specifically, the recall affects Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets in both 30-count and 90-count bottles. The affected lot number is 12251163A/B, with an expiration date of May 31, 2027. While the brand-name Tribenzor is not part of this recall, individuals using generic versions are advised to verify their medication.

Consumers possessing the recalled medication are generally advised by the FDA to consult with their healthcare provider before altering their treatment routine. While Class II recalls typically allow continued use unless otherwise advised, professional medical guidance is recommended to ensure patient safety and appropriate medication management.